Lion Biotechnologies - 48 Year Dividend History | IOVA

Historical dividend payout and yield for Lion Biotechnologies (IOVA) since 1971. The current TTM dividend payout for Lion Biotechnologies (IOVA) as of June 17, 2019 is $0.00. The current dividend yield for Lion Biotechnologies as of June 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.359B $0.000B
Iovance Biotherapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. Iovance Biotherapeutics Inc., formerly known as Lion Biotechnologies Inc., is based in SAN CARLOS, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83